Почетна › Остеосарком › Тексас
Kliničke studije za Остеосарком u državi Тексас
12 studija za Остеосарком traži učesnike na lokacijama u državi Тексас.
Gradovi u državi Тексас
Zvanični tekst studije (na engleskom)
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Children's Medical Center, Dallas
Тражи се учесникФаза 1/2
До 30 година · Оба пола · Ажурирано 12. 11. 2026. · NCT06541262Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Тражи се учесникФаза 2
Узраст од 12 до 39 · Оба пола · Ажурирано 12. 11. 2026. · NCT04616560Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- The University of Texas MD Anderson Cancer Center, Houston
Тражи се учесникФаза 1
Узраст од 12 до 50 · Оба пола · Ажурирано 10. 11. 2026. · NCT03093909Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
- Texas Children's, Houston
Тражи се учесникФаза 1
Узраст од 1 до 30 · Оба пола · Ажурирано 19. 10. 2026. · NCT07144254Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
- UT Southwestern, Dallas
- Texas Tech University Health Sciences Center, Lubbock
Тражи се учесникФаза 1
12 Months – 20 Years · Оба пола · Ажурирано 8. 10. 2026. · NCT02013336Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study
- M D Anderson Cancer Center, Houston
Тражи се учесникФаза 2
Узраст 12 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT05019703Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Children's Medical Center, Dallas
Тражи се учесникФаза 1/2
До 26 година · Оба пола · Ажурирано 3. 9. 2026. · NCT06465199Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Тражи се учесникФаза 1/2
12 Months – 30 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT04851119Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- Medical City Dallas Hospital, Dallas
- и још 8
Тражи се учесникФаза 3
До 50 година · Оба пола · Ажурирано 25. 8. 2026. · NCT05235165NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma
- Texas Children's Hospital, Houston
Тражи се учесникФаза 1
Узраст од 1 до 24 · Оба пола · Ажурирано 21. 7. 2026. · NCT07211737Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- University of Texas Health Science Center at San Antonio, San Antonio
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 18. 5. 2026. · NCT01790152HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
- Texas Children's Hospital, Houston
Тражи се учесникФаза 1
Узраст од 1 до 25 · Оба пола · Ажурирано 22. 1. 2026. · NCT04995003Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.